Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 275-156-8 | CAS number: 71048-82-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation / corrosion
- Remarks:
- other: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP complaint, guideline study, available as unpublished report, no restrictions, fully adequate for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: OECD draft proposal: In Vitro Skin Irritation: Reconstructed Human Epidermis (RhE) Test Method
- Qualifier:
- according to guideline
- Guideline:
- other: EU Method B.46: In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test
- GLP compliance:
- yes
Test material
- Reference substance name:
- 1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-2-buten-1-one
- EC Number:
- 260-709-8
- EC Name:
- 1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-2-buten-1-one
- Cas Number:
- 57378-68-4
- IUPAC Name:
- 1-(2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one
- Details on test material:
- Description: clear colourless to pale yellow liquid
Batch: 2030337
Purity: 97.6%
Test substance storage: in refrigerator (2-8°C) in the dark
Stability under storage conditions: stable
Expiry date: 18 January 2011
Constituent 1
Test animals
- Species:
- other: not applicable
- Strain:
- other: not applicable
Test system
- Type of coverage:
- open
- Preparation of test site:
- other: Human skin tissue
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: not applicable
- Amount / concentration applied:
- Test substance: 10 μl
Negative control: Phosphate buffered saline (PBS, Invitrogen Corporation, Breda, The Netherlands)
Positive control: 5% (aq) Sodium dodecyl sulphate (SDS, Sigma Aldrich, Zwijndrecht, The Netherlands) (CAS Number 151-21-3) - Duration of treatment / exposure:
- 15 minutes
- Observation period:
- After a 42 hour incubation period.
- Number of animals:
- Not applicable
- Details on study design:
- Test system: EPISKIN Standard Model (EPISKIN-SM, 0.38 cm², Lot no.: 10-EKIN-010). This model is a three-dimensional human epidermis model, which consists of adult human-derived epidermal keratinocytes which have been seeded on a dermal substitute consisting of a collagen type I matrix coated with type IV collagen. The keratinocytes were cultured for 13 days, which results in a highly differentiated and stratified epidermis model comprising the main basal, supra basal, spinous and granular layers and a functional stratum corneum.
Preparation and preincubation;
-Tissues: on the day of receipt the tissues were transferred to 12-well plates and preincubated with prewarmed Maintenance Medium for 24 hours at 37°C. The level of Maintenance Medium was just beneath the tissue. Maintenance Medium and Assay medium were supplied by Skinethic Laboratories, Nice, France.
- MTT medium: MTT concentrate (3 mg/ml in PBS) diluted (10x) in Assay medium (final concentration 0.3 mg/ml) Sigma Aldrich, Zwijndrecht, The Netherlands)
- Environmental conditions: All incubations, with the exception of the test substance incubation of 15 minutes at room temperature, were carried out in a controlled environment, in which optimal conditions were a humid atmosphere of 80 - 100% (actual range 91 - 94%), containing 5.0 ± 0.5% CO2 in air in the dark at 37.0 ± 1.0°C (actual range 37.0 - 37.5°C). Temperature and humidity were continuously monitored throughout the experiment. The CO2 percentage was monitored once on each working day.
Study design:
1. Test for reduction of MTT by the test substance; Delta Damascone was checekd for possible direct MTT reduction before the study was started. To access the ability of the test substance to reduce MTT, approximatley 10 μl of test substance was added to a 12 well plate filled with 2 ml MTT solution (0.3 mg/ml). The mixture was incubated for approximately 3 hours at 37°C. A negative control, sterile Milli-Q water was tested concurrently.
1. Application/Treatment of the test substance; The test was preformed on a total of 3 tissues per test substance together with negative and positive controls. Ten μl of the undiluted test substance was added (with a pipette) into 12-well plates on top of the skin tissues. Three tissues were treated with 10 μl 5% SDS (positive control) respectively. The positive control was respread after 7 minutes contact time. After the exposure period of 15 minutes at room temperature, the tissues were washed with phosphate buffered saline to remove residual test substance. After rinsing the cell culture inserts were each dried carefully. The skin tissues were kept in new 12-well plates on 2 ml pre-warmed maintenance medium until all tissues were dosed and rinsed. Subsequently the skin tissues were incubated for 42 hours at 37°C.
3. Cell viability measurement; After incubation, cell culture inserts were dried carefully to remove excess medium and were transferred into a 12-wells plate prefilled with 2 ml MTT-medium (0.3 mg/ml). The tissues were incubated for 3 h at 37°C. After incubation the tissues were placed on blotting paper to dry the tissues. Total biopsy was made by using a biopsy punch. Epidermis was seperated from the collagen matrix and both parts were placed in prelabeled microtobes and extrated with 500 μl isopropanol. Tubes were stored refrigerated and protected from light for 70 hours. The amount of extracted formazan was determined spectrophotometrically at 570 nm in duplicate with the Multiskan Spectrum (Thermo Labsystems).
Cell viability was calculated for each tissue as a precentage of the mean of the negative control tissues. Skin irritation potential of the test substance was classified according to remaining cell viability following exposure of the test substance.
Electronic data capture; Obeservations/measurements in the study were recorded electronically using the following programme(s): REES centron Environmental Monitoring system version SQL 2.0 (REES Scientific, Trenton, NJ, USE): Temperature and humiduty.
Multiskan spectrum version 1.00 (Thermo labsystems, Breda, The Netherlands) for optical density measurement.
Interpretation:
1. acceptability of the assay; The in vitro skin test is considered acceptable if it meets the following criteria:
a.) The absolute mean OD 570 (optical density at 570 nm) of the three tissues of the negative control should reasonably be within the laboratory historical control data range and the Standard Deviation value (SD) of the % viability should be ≤ 18.
b.) The mean relative tissue viability of the positive control should be ≤40% relative to the negative control and the Standard Deviation value (SD) of the % viability should be ≤18.
c) The SD calculated from individual % tissue viabilities of the three identically treated replicates should be ≤18.
2. Data evaluation and statistical procedures; A test substance is considered irritant in the skin irritation test if: The relative mean tissue viability of three individual tissues after 15 minutes of exposure to the test substance and 42 hours of postincubation is ≤ 50% of the mean viability of the negative controls.
A test substance is considered non-irritant in the skin irritation test if: The relative mean tissue viability of three individual tissues after 15 minutes of exposure to the test substance and 42 hours of postincubation is > 50% of the mean viability of the negative controls.
Results and discussion
In vivo
Results
- Irritation parameter:
- other: tissue viability (% of control)
- Basis:
- other: mean of three tissue culture wells
- Time point:
- other: 42 h
- Score:
- 5
- Max. score:
- 100
- Reversibility:
- other: examination of reversibility is not part of this study
- Other effects:
- In a three-dimensional human epidermis model (EPISKIN Standard Model), application of delta-damascone directly to the skin tissue resulted in a mean of 5% cell viability (percentage of control) after an incubation period of 42 hours.
Any other information on results incl. tables
Delta Damscone was checked for possible direct MTT reduction by adding the test substance to MTT medium. Because no colour change was observed it was concluded that Delta Damascone did not interact with MTT.
Skin irritation is expressed as the remaining cell viability after exposure to the test substance. The relative mean tissue viability obtained after 15 minutes treatment with Delta Damascone compared to the negative control tissues was 5%. Since the mean relative tissue viability for Delta Damascone was below 50% it is considered to be irritant.
The positive control had a mean cell viability after 15 minutes of exposure of 5%. The absolute mean OD570 of the negative control tissues was within the laboratory historical control data range. The standard deviation value of the precentage viability of three tissues treated identically was less than 18%, indicating that the test system functioned properly.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.